Jennifer Kim

Stock Analyst at Cantor Fitzgerald

(3.47)
# 916
Out of 4,966 analysts
35
Total ratings
54.29%
Success rate
20.09%
Average return

Stocks Rated by Jennifer Kim

Belite Bio
May 15, 2025
Reiterates: Overweight
Price Target: n/a
Current: $63.03
Upside: -
Precigen
May 15, 2025
Reiterates: Overweight
Price Target: n/a
Current: $4.51
Upside: -
Insmed
Feb 20, 2025
Reiterates: Overweight
Price Target: n/a
Current: $136.10
Upside: -
Fortress Biotech
Jun 20, 2024
Reiterates: Overweight
Price Target: n/a
Current: $2.58
Upside: -
EyePoint Pharmaceuticals
Jun 20, 2024
Reiterates: Overweight
Price Target: n/a
Current: $11.57
Upside: -
Ocugen
Aug 31, 2023
Maintains: Overweight
Price Target: $2.5$2
Current: $1.02
Upside: +96.08%
Lipocine
Jul 27, 2023
Reiterates: Overweight
Price Target: $33
Current: $2.91
Upside: +1,034.02%
ProQR Therapeutics
May 17, 2023
Maintains: Overweight
Price Target: $5$4.5
Current: $2.25
Upside: +100.00%
Aytu BioPharma
May 17, 2022
Maintains: Overweight
Price Target: $220$100
Current: $2.35
Upside: +4,155.32%